Navigation Links
$7.5 million to JAX from South Korean government for cancer genomics project
Date:1/22/2014

The Jackson Laboratory, in collaboration with Seoul National University, will receive a five-year, $7.5 million grant from the South Korean government for a large-scale cancer genomics project employing the latest sequencing technology and special JAX mouse models that can host human tumors.

"This is a wonderful example of the international collaborations that JAX is building to rapidly advance its research mission, in this case: individualized cancer diagnosis and treatment," said Charles Lee, Ph.D., director of The Jackson Laboratory for Genomic Medicine and leader of the JAX component of the project,

Lee, who is also a distinguished visiting professor at Seoul National University, will work with principal investigator Jong-Il Kim, M.D., Ph.D., of the Seoul National University College of Medicine and other academic collaborators in Seoul.

During the first phase of the grant (2013-15), Kim and colleagues will collect and store tumors from patients with gastric, breast, colon, lung and rare cancers, and sequence and determine the genomic signatures of those cancers.

Lee will lead the development of hundreds of new mouse model systems for gastric, breast and other cancers that will be made available to the worldwide scientific community. The so-called PDX models (for patient-derived xenograft) represent mice that carry human tumors, enabling detailed functional study of the cellular and genomic characteristics of specific cancers.

The research team will also build a publicly accessible library of anticancer drugs and establish a drug efficacy screening system using patient-derived primary cell lines and PDX mouse models.

Lee explains that the researchers expect to find genetic similarities among certain cancers. "If we look at 1,000 gastric cancers, their genetic signatures may group into, say, 20 clusters. We can then do preclinical testing on just a few tumors from each of those groups, testing different drugs or combinations of drugs to determine which therapies are most effective for treating those tumors with a given genetic signature."

During the grant's second phase (2016-17), the researchers will take the project to the clinic, developing a personalized anticancer drug screening system and establishing a clinical trial network for individualized medicinal screening.

"This grant from the South Korean government shows there's international interest in The Jackson Laboratory's approach to cancer research using PDX models," Lee says.


'/>"/>

Contact: Joyce Peterson
joyce.peterson@jax.org
207-288-6058
Jackson Laboratory
Source:Eurekalert

Related biology news :

1. Dartmouth-led team gets $8 million grant to research arsenic in children
2. With $1.6 million award, biochemist tackles diabetes
3. Autism Speaks awards nearly $2.7 million for new research projects
4. After a 49-million-year hiatus, a cockroach reappears in North America
5. Physicians awarded $4 million to study effects of fertility treatments and obstetric care
6. Algae to crude oil: Million-year natural process takes minutes in the lab
7. UT Dallas awarded $1 million to improve prosthetics for soldiers
8. Pitt-led network gets $70 million over 7 years to develop, test HIV prevention products
9. A new species of horse, 4.4 million years old
10. EPA awards $1 million grant to NJITs Brownfield program
11. Army renews bio-inspired engineering and science research center at UC Santa Barbara with $48 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2016)... http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ( ... --> DERMALOG, le leader de l,innovation ... d,empreintes digitales pour l,enregistrement des réfugiés en Allemagne. ... produire des cartes d,identité aux réfugiés. DERMALOG dévoilera ...
(Date:3/10/2016)... March 10, 2016   Unisys Corporation (NYSE: ... Protection (CBP) is testing its biometric identity solution at ... to help identify certain non-U.S. citizens leaving the ... test, designed to help determine the efficiency and accuracy of ... February and will run until May 2016. --> ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
(Date:5/19/2016)... 2016 There is no saying ... the relentless pressures in pricing and lack in consumer ... circle though - numerous opportunities are up for grabs ... ActiveWallSt.com,s presents four names in this sector: Portola Pharmaceuticals ... (NASDAQ: VTAE ), Anthera Pharmaceuticals Inc. (NASDAQ: ...
(Date:5/18/2016)... Calif. (PRWEB) , ... May 18, 2016 , ... ... awarded the Luis Villalobos Award to Cognition Therapeutics at the annual ACA Summit last ... company that is financed by one of ACA’s member angel groups. It is the ...
(Date:5/18/2016)... Washington, PA (PRWEB) , ... May 18, 2016 ... ... at least 1,200 hospitalizations are a direct result of asthma complications.* Costing more ... challenge across the country. , “For too many, the suffering ...
Breaking Biology Technology: